Cooperative Agreement U48DP006955
- This federal Cooperative Agreement award of $498,623.00, awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the University of South Carolina in optimizing and projecting lifestyle behavioral interventions to sustain long-term health behaviors and outcomes in focus populations. The project aims to implement evidence-based strategies to decrease type 2 diabetes risk, improve...
- This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) provides $350,000.00 in funding to the University of Illinois to develop strategies for leveraging Federally Qualified Health Centers (FQHCs) as trusted community partners to improve diabetes management. The project aims to enhance diabetes prevention, self-care practices, and health equity by implementing evidence-based...
- This Cooperative Agreement award, valued at $492,348.00 and awarded by the National Center for Chronic Disease Prevention and Health Promotion, is part of the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award will support the University of Pittsburgh in implementing evidence-based lifestyle change interventions to improve health outcomes related to diabetes. The project aims to decrease type 2 diabetes risk, improve self-care practices, enhance diabetes care...
- This federal Cooperative Agreement award, valued at $350,000.00, is funded by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award, with a period of performance from September 30, 2025 to September 29, 2028, supports Clemson University in evaluating the Health Extension for Diabetes Program, a community-clinical linkage program. The objective of the project is to implement evidence-based strategies to...
- This $699,999 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the NYU LANGONE HEALTH COORDINATING CENTER FOR CASSIDY (NYU COC) located in New York. The award, effective from September 30, 2025 to September 29, 2029, funds research, surveillance, community interventions, and health system improvements targeting priority populations experiencing diabetes-related health...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) supports the establishment of a nationwide diabetes surveillance system for youth and young adults. The $500,000 award, with a performance period from September 30, 2025 to September 29, 2029, will fund research on the incidence, prevalence, risk factors, disparities, and social determinants of health related to diabetes in this...
- This federal Cooperative Agreement award of $349,943.00 was provided by the National Center for Chronic Disease Prevention and Health Promotion, under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) federal grant program. The award was granted to The Regents of the University of California, doing business as the University of California, Berkeley, to conduct research on the impact of the CMS Accountable Health Communities Model on racial equity of diabetes care and...
- This federal Cooperative Agreement award for the "ENHANCED VISIBILITY, ENGAGEMENT, AND REACH OF LIFESTYLE CHANGE INTERVENTIONS PROJECT (EVER-LCI) AND LCIRN COORDINATING CENTER" was provided by the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The $996,369.00 award to the University of Utah will support a 2-year project period...
- The Centers for Disease Control and Prevention (CDC) awarded a $499,971 Cooperative Agreement under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) to the Ann & Robert H Lurie Children's Hospital of Chicago. The award, with a performance period from September 30, 2025 to September 29, 2029, will support the "Chicago Area Surveillance, Statistics, and Analysis Network for Diabetes, with Representative Ascertainment" project. This project aims to implement...
- The federal Cooperative Agreement award of $499,972 was provided by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award was granted to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to support research, surveillance, community interventions, and health system improvements targeting diabetes prevention, management, and health equity in the Pacific Northwest. The award...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), provides $499,993.00 in funding to the University of Massachusetts Medical School (UMASS Medical) to implement research on lifestyle change interventions that address diabetes prevention and management. The award runs from September 30, 2025 to September 29, 2027. As an academic medical center and research institution, UMASS Medical will leverage its expertise in biomedical research, healthcare service delivery, and collaboration with federal agencies to support evidence-based strategies that decrease type 2 diabetes risk, improve self-care practices, enhance diabetes care quality, and develop childhood obesity interventions as a diabetes prevention approach. The funding will enable UMASS Medical to contribute to the CDC's broader efforts to address diabetes prevention, management, and health equity nationwide through this Lifestyle Change Implementation Research Network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $500.0k | 9/23/25 |